Randal Mills left Osiris Therapeutics a few years after the company won the first-ever approval for a stem cell therapy and wasn't sure where he'd go next, but Mills ended up moving across the country to help California's stem cell research funding agency decide how best to spend its last $800m.
The California Institute of Regenerative Medicine (CIRM) was created in late 2004 when voters approved a measure that allowed the state to generate $3bn in bond sale proceeds to fund stem cell research
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?